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Abstract Correlation between cell cycle progression and 
endogenous levels of plant hormones was studied in synchronized 
tobacco BY-2 cell suspension cultures. Sixteen different cytoki- 
nins, indole-3-acetic acid (IAA) and abscisic acid (ABA) were 
extracted using solid-phase anion exchange chromatography in 
combination with immunoaffinity purification, and quantified by 
mass spectrometry. No significant correlation could be identified 
for IAA and ABA. In contrast, there were sharp peaks in the 
levels of specific cytokinins (zeatin- and dihydrozeatin-type) at
the end of the S phase and during mitosis. The levels of other 
cytokinins analyzed, including zeatins N- and O-glucosides, 
remained low, suggesting that the increased amounts of their 
corresponding non-glucosylated form resulted from de novo 
synthesis. These f'mdings uggest hat zeatin- and dihydrozeatin- 
type cytokinins might play a specific regulatory role in the 
progression of the plant cell cycle. One hypothesis to explain 
cytokinin action is based on a specific interaction with kinases 
that regulate cell cycle progression, as has been recently shown 
for the cytokinin analogue olomoucine. 
Key words: Cell cycle; Cytokinin; Mass spectrometry; Plant 
hormone; Synchronization; Tobacco BY-2 cell 
1. Introduction 
The basic mechanism of cell cycle control appears to be 
conserved among eukaryotes and key regulators uch as cy- 
clin-dependent kinases (CDK) and their activating cyclin sub- 
units have also been identified in plants (for a review see [1,2]). 
Although the yeast, animal, and plant cell cycle share many 
features, its mode of regulation differs in each type of organ- 
ism. In plants, cell division is influenced by intrinsic develop- 
mental programs and by environmental factors, which can 
both act through regulation of the levels of plant hormones. 
In particular, the plant hormones auxin and cytokinin have 
dramatic effects on cell division [3]. Cytokinins were first dis- 
covered by their ability to promote plant cell division [4], but 
by now have been implicated in almost all stages of plant 
growth and development (for a review see [5]). Similarly, aux- 
ins have been shown to be involved in cell division, cell elon- 
gation, and cell differentiation [6]. Cytokinins and auxins can 
interact both synergistically and antagonistically; for example, 
both are required to stimulate cell division in cultured tobacco 
pith tissues [7], but oppose each other in the control of shoot 
and root initiation in tissue cultures and in the maintenance of
apical dominance [8]. Based on functional assays, cytokinins 
were suggested to be involved in the passage through several 
restriction points of the plant cell cycle [9-11], There is also 
evidence for the involvement of other plant hormones, such as 
abscisic acid [12], gibberellins [13], ethylene [14], and poly- 
amines [15] in the regulation of cell division. Although the 
effects of phytohormones on plant growth have been studied 
extensively, not much is known about fluctuations in the levels 
of endogenous hormones during the cell cycle. Here, we re- 
port the analysis of 16 different naturally occurring cytoki- 
nins, indole-3-acetic acid (IAA), and abscisic acid (ABA), 
throughout the cell cycle of synchronized tobacco BY-2 [16] 
cell suspension cultures. Our findings suggest hat specifically 
zeatin-type (Z-type) cytokinins, and possibly also their dihy- 
dro derivatives, might play a regulatory role during the cell 
cycle. 
2. Material and methods 
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Abbreviations: ABA, abscisic acid; CDK, cyclin-dependent kinase; 
2,4-D, 2,4-dichlorophenoxyacetic ac d; DEAE, diethylaminoethyl; 
DZ, dihydrozeatin; DZNG, dihydrozeatin-N-glucoside; DZMP, dihy- 
drozeatin riboside-5'-monophosphate; DZOG, dihydrozeatin-O-glu- 
coside; DZROG, dihydrozeatin riboside-O-glucoside; DZR, 
dihydrozeatin riboside; GC, gas chromatography; gfw, gram fresh 
weight; 2iP, isopentenyladenine; 2iP9G, isopentenyladenine-9-gluco- 
side; IAA, indole-3-acetic a id; iPMP, isopentenyladenosine-5'-mono- 
phosphate; iPNG, isopentenyladenine-N-glucoside; 2iPA, 
isopentenyladenosine; LC, liquid chromatography; MAP, microtubule 
associating protein; MS, mass pectrometry; RP, reversed phase; SIM, 
single-ion monitoring; Z, zeatin; Z9G, zeatine-9-glucoside; ZMP, 
zeatin riboside-5'-monophosphate; ZNG, zeatin-N-glucoside; ZOG, 
zeatin-O-glucoside; ZR, zeatin riboside; ZROG, zeatin riboside-O- 
glucoside 
2.1. Chemicals 
All cytokinin-deuterated racers ([2H.5]-Z, [2Hs]-ZR , [2Hs]-Z9G, 
[2Hs]-ZOG, [2H~]-ZROG, [2Hr]-2iP, [2H~]-2iPA, [2Hr]-2iP9G, [~H3]- 
DZMP) were purchased from Apex (Honiton, UK). [lsO]-ABA was 
prepared according to [17] and [13Cr]-IAA was purchased from Cam- 
bridge Isotope Lab (Woburn, MA). Radioactive tracers were obtained 
from the Institute of Experimental Botany, Isotope Laboratory (Pra- 
gue, Czech Republic): [2-3H]-(trans)-zeatin riboside (0.9 Tbq/~tmol) 
and [2-3H]-(trans)-zeatin (0.9 Tbq/~mol). Alkaline phosphatase (10 
mg/ml, 2500 U/mg, EIA grade) was purchased from Boehringer- 
Mannheim (Mannheim, Germany). RP-C18 columns (0.5 g) were pur- 
chased from Varian (San Fernando, CA) and DEAE Sephadex (A-25) 
from Pharmacia Biotech (Uppsala, Sweden). 
2.2. Culture maintenance and synchronization 
The Nicotiana tabacum BY-2 ceils require the exogenous supple- 
mentation of auxin, but not cytokinin, for its growth. The culture 
was maintained as described [16] by a weekly 70-fold dilution in 
modified Linsmaier and Skoog medium supplemented with 0.2 mg/1 
of the auxin 2,4-dichlorophenoxyacetic acid (2,4-D). The cells were 
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cultured on a rotary shaker at 130 rpm at 27°C in the dark. The 
cultures were synchronized as described by Nagata et al. [16]. Briefly, 
a stationary culture was diluted 10-fold in fresh medium supplemented 
with 5 mg/l aphidicolin. After 24 h, the drug was removed by exten- 
sive washing and the cells were resuspended in fresh medium. Samples 
of cell culture (4 ml, corresponding to = 0.25 gfw of cells) were left to 
sediment on ice, the supernatant was removed completely and re-cen- 
trifuged to eliminate remainders of cells, and both the cells and the 
supernatant were immediately frozen in liquid nitrogen and stored at 
-70°C. To determine the mitotic index, cells were fixed in ethanol/ 
acetic acid (3:1, v/v) and stained with 2% orcein in lactic acid/propio- 
nic acid (1 : 1, v/v). Nuclei at late prophase to telophase were scored by 
microscopic analysis of 300 cells. 
2.3. Extraction and purification of cytokinins, IAA, and ABA 
Frozen cells (0.2~0.3 g) were extracted overnight at -20°C in 
CHC13/CH3OH/H20/HCOOH (5:12:2:1) (Bieleski solvent) [18]. The 
use of this solvent during the extraction procedure nsured that hy- 
drolysis of the cytokinin nucleotides did not occur. Deuterated cyto- 
kinins, [lsO]-ABA and [13Cr]-IAA were added as internal standards 
(50 ng each). After centrifugation (24000×g, 4°C, 20 min), organic 
solvent from the supernatant was evaporated in vacuo and the pH of 
the resulting water phase was adjusted to 7. This extract was loaded 
on a combination of a pre-immune serum column, an IAA immunoaf- 
finity column [19] and an ABA immunoaffmity column [20]. The ef- 
fluent, containing the cytokinins, was then further purified on a com- 
bination of a DEAE sephadex (2 ml, HCO3- form) and a RP-C18 
column. After rinsing the affinity columns with water, the IAA and 
ABA immunoaffinity columns were eluted with 4 ml of ice-cold 100% 
methanol and immediately rinsed with water. The fractions containing 
IAA and ABA were dried under vacuum and stored at -70°C until 
further analysis by GC-MS. After washing the DEAE sephadex and 
RP-C18 columns with water, the fraction eluting from the RP-C18 
column with 10 ml of 80% methanol contained the cytokinin-free 
bases, ribosides, and glycosides. The eluate was dried in vacuo to 
remove the methanol and then applied to a combination of a cytoki- 
nin immunoaffinity and a RP-C18 column. The immunoaffinity col- 
umns were prepared with monoclonal ZR antibodies able to bind a 
broad spectrum of cytokinins [21]. After washing with 10 ml of water, 
the immunoaffinity column was eluted with 4 ml of ice-cold 100% 
methanol and immediately rinsed with water. The methanol eluate 
from the immunoaffinity column contained the cytokinin-free bases, 
ribosides, and N-glucosides. The cytokinin O-glucosides were not re- 
tained on the immunoaffmity column, and were eluted from the RP- 
C18 column with 4 ml of 80% methanol. 
The cytokinin nucleotides which were bound to the DEAE Sepha- 
dex column, were eluted with 10 ml of 1 M NH4HCO3. These were 
then retained on another RP-C18 column, and removed by eluting 
with 10 ml of 80% methanol. The eluate was dried by rotary film 
evaporation and re-dissolved in 0.01 M Tris.HCl (pH 9). The cytoki- 
nin nucleotides were treated with alkaline phosphatase (30 min, 37°C) 
and the resulting nucleosides were further purified by immunoaffmity 
chromatography as described above. Samples were stored at -70°C 
until analysis by LC-MS/MS. 
2.4. High-performance liquid chromatography (HPLC)-UV spectrum 
detection 
Radioactive tracers ([aH]-ZR, [3H]-Z, 450 Bq of each) were added 
to each sample to determine the recovery, and extraction and purifi- 
cation was performed as described above. The cytokinins were sepa- 
rated on a Microsorb C18 column (150 mm, 4.6 mm i.d, 5 pan particle 
size; Rainin, Woburn, MA) at a flow rate of 0.5 ml/min using a 
gradient of solvent A (10% methanol in 40 mM triethylammonium 
acetate, pH 3.35) and solvent B (80% methanol in 30 mM acetic acid). 
The following gradient profile was used: 0 rain, 90% A + 10% B; 20 
min, 50% A + 50% B; 39 min, 45% A + 55% B; 40 min 100% B [22]. 
Fractions of 0.25 ml were collected and 3 ml of LSC cocktail (Ultimo 
Gold, Packard) was added for tritium counting (Tricarb 1500, Pack- 
ard). Corrections for quenching of the radioactivity were made. 
The UV absorbance between 240 and 300 nm was monitored on 
line with a diode array detector (Waters PDA991), with absorption at 
268 nm being used for quantification. The identity of the eluting 
compounds was confirmed using the full-scale spectrum at the appro- 
priate retention time. Recovery calculations were made via isotope 
dilution. 
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2.5. Quantitative analysis of cytokinins by electrospray tandem mass 
spectrometry 
Cytokinin fractions were quantified by HPLC linked to a Quatro II 
mass spectrometer (Fisons) equipped with an electrospray interface 
((+)ES LC-MS/MS). Ten-microliter samples were injected on a RP- 
C8 column (Merck; LiChrosphere 60 RP Select B; 5 I.tm; 125×4 ram) 
and eluted with methanol/0.01 M ammonium acetate (70:30, v/v) at 
800 I.tl/min. Using a post-column split of 1/20, the effluent was intro- 
duced into the electrospray source (source temperature 80°C, capillary 
voltage +3.5 kV, cone voltage 20 V). Quantification was obtained by 
multiple reaction monitoring (MRM) of (MH) + and the appropriate 
product ion [23]. Endogenous concentrations were calculated, taking 
into account he abundance ratio of the diagnostic ions corresponding 
to the unlabelled and labelled (deuterated) compounds. 
2.6. Analysis of ABA and lAA by GC-MS 
Prior to GC-MS analysis the ABA and IAA samples were methyl- 
ated with diazomethane [24], dried under nitrogen and stored at 
-70°C. GC-MS analysis was performed on a VG TRIO 2000 Mass 
Spectrometer (CI -  mode) linked on line with a Hewlett Packard 5890 
series II gas chromatograph equipped with a 14 m, 0.25 mm i.d., 0.25 
rm DB1 stationary phase column. For ABA analysis, the following 
temperature gradient was used: 80-120°C (25°C/min), 120-220°C 
(15°C/min), 220-300°C (40°C/min). The diagnostic ions were at rrdz 
278 and 280 corresponding to methyl-ABA and 180-methyl-ABA, 
monitored in single-ion monitoring (SIM) mode. After methylation, 
the IAA fractions were derivatized with heptafluorobuturyl imidazole 
(HFBI) [25]. GC-MS analysis was performed in the electron impact 
(EI+) mode with the following temperature gradient: 40-95"C (25°C/ 
min), 95-115°C (5°C/min), 115-300°C (35°C/min). The diagnostic ions 
were at m/z 326 and 332 corresponding to methyl-IAA-HFB and 
13C6-methyl-IAA-HFB , monitored in SIM. 
3. Results 
3.1. Synchronization of the BY-2 cells 
To study the endogenous levels of cytokinins, IAA and of 
ABA during the cell cycle, a tobacco BY-2 cell suspension 
culture was synchronized using aphidicolin (see Section 2). 
Aphidicol in inhibits DNA polymerase ct [26,27], and arrest 
the cells in early S-phase. Samples were taken immediately 
before (0 h) and at various intervals after the release of the 
cells from the aphidicolin block, and the levels of the various 
plant hormones were determined in the cells as well as in the 
growth medium. A peak of about 34% in the mitotic index 
was observed approximately 7 h after aphidicolin wash (Fig. 
1A, 2A, and 3A). Independent experiments in which the levels 
of histone H4 mRNA were analyzed in synchronized BY-2 
cultures that exhibited similar kinetics of the mitotic index, 
indicated that the S phase is completed 3 h after aphidicolin 
wash [28]. 
3.2. Cytokinin levels in the synchronized cells 
Cytokinin levels were quantified in three independent ex- 
periments and by using two different methods, HPLC-UV 
spectrum detection and LC-MS/MS. Using HPLC-UV detec- 
tion, we determined only the levels of zeatin type (Z-type) 
cytokinins, namely zeatin (Z), zeatin riboside (ZR) and zeatin 
r iboside-5' -monophosphate (ZMP) (this experiment is referred 
to as Experiment 1). The levels of these cytokinins in the 
synchronized cells are presented in Fig. 1. Approximately 3
h after release of the cells from aphidicolin block, correspond- 
ing with the end of the S phase, we observed an increase in the 
levels of Z (peak value of 140 pmol/gfw) and ZR (peak value 
of  120 pmol/gfw). No change in ZMP levels was observed at 
this stage of the cell cycle. An increase in all three cytokinins 
coincided with the peak of the mitotic index: Z (peak value of 
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Fig. 1. Analyses of cytokinin levels in synchronized BY-2 cells by 
HPLC-UV spectrum detection (Exp. 1). (A) Mitotic index of the 
cells immediately before (0 h) and at different intervals after release 
from aphidicolin block. (B) Levels of Z (ll), ZR ([]) and ZMP (• )  
in the synchronized cells (concentrations in pmol/gfw of cells in a 
4-rnl sample). 
150 pmol/gfw), ZR (peak value of 70 pmol/gfw) and ZMP 
(peak value of 140 pmol/gfw). Finally, at around 10 h, corre- 
sponding to the G1 phase, a third increase in Z (peak value of 
120 pmol/gfw) was measured. 
To study whether the levels of other cytokinins also fluctu- 
ate during the cell cycle, 16 different naturally occurring cyto- 
kinins were analyzed by means of MS. Two independent ex- 
periments are presented here and are referred to as Exps. 2 
and 3 (Figs. 2 and 3, respectively). Among the cytokinins 
analyzed, those present in the cells at highest levels in both 
experiments were of the Z-type: Z, ZR, and ZMP. In Exp. 2, 
the levels of these cytokinins in the cells peaked at similar cell 
cycle phases compared with Exp. 1, in which the cytokinins 
were analyzed by HPLC-UV spectrum detection (Fig. 2B and 
1B, respectively). Approximately 3 h after the release of the 
cells, a peak of Z (peak value of 200 pmol/gfw) and ZR (peak 
value of 80 pmol/gfw) was detected, while ZMP levels were 
not changed. Coinciding with the peak in mitotic index, sharp 
increases in the levels of Z (peak value of 290 pmol/gfw), ZR 
(peak value of 90 pmol/gfw) and ZMP (peak value of 350 
pmol/gfw) were observed. Nine hours after the release, corre- 
sponding to the G1 phase, there was an increase in the level of 
Z (peak value of 230 pmol/gfw). In Exp. 3 (Fig. 3), there was 
a higher variability in the levels of the Z-type cytokinins at the 
early stages of the cell cycle, that did not allow the identifica- 
tion of clear peaks at the end of the S phase, and no peak in Z 
levels could be detected at the G1 phase. Similar to the pre- 
vious experiments, the levels of all three cytokinins increased 
coinciding with the peak of mitotic index, although the rela- 
tive abundance of ZR and ZMP was different (Fig. 3B): Z 
(peak value of 240 pmol/gfw), ZR (peak value of 500 pmol/ 
gfw), and ZMP (peak value of 85 pmol/gfw). 
Analyses of dihydrozeatin-type (DZ-type) cytokinins in the 
synchronized cells (Fig. 2C and 3C) indicated that these com- 
pounds were present at lower levels compared to the Z-type 
cytokinins (note the different scales in part B and C of each 
figure). In Exp. 2, and much less pronounced in Exp. 3, there 
was an increase in dihydrozeatin riboside (DZR) levels at the 
end of the S phase. During the peak of mitotic index there 
was an increase in the levels of dihydrozeatin (DZ) and of 
DZR, and in Exp. 2 also of dihydrozeatin riboside-5'-mono- 
phosphate (DZMP). 
In both Exps. 2 and 3, the levels of the cytokinin N- and 
O-glucosides analyzed were either very low or did not change 
significantly in cells at different phases of the cell cycle (data 
not shown). Zeatin-N-glucoside (ZNG) and dihydrozeatin-N- 
glucoside (DZNG) concentrations were close to or under the 
detection limit of 1 pmol/gfw. The levels of zeatin-O-glucoside 
(ZOG) and dihydrozeatin-O-glucoside (DZOG) were approxi- 
mately 30 and 15 pmol/gfw, respectively, throughout the en- 
tire cell cycle. The levels of zeatin riboside-O-glucoside 
(ZROG) and dihydrozeatin riboside-O-glucoside (DZROG) 
were close to or under the detection limit of 4 pmol/gfw. In 
addition, no significant changes in the levels of endogenous 
isopentenyladenine-type (iP-type) cytokinins could be identi- 
fied in the cells (data not shown). The steady-state concentra- 
tion of isopentenyladenine (2iP) was around 15 pmol/gfw. The 
levels of isopentenyladenosine (2iPR) and isopentenyladenine- 
N-glucoside (2iPNG) were close to the detection limit of 3 
pmol/gfw, whereas isopentenyladenosine-5'-monophosphate 
(2iPMP) levels were below the detection limit of 2 pmol/gfw. 
In all three experiments, the levels of cytokinins detected in 
the growth medium of the synchronized cells were close to or 
below the detection limit (,~ 0.5-5 pmol/ml medium for the 16 
different cytokinins analyzed) (data not shown), and no sig- 
nificant change in the levels of any of these cytokinins in the 
medium could be detected in the course of culture synchroni- 
zation. 
3.3. Analyses of  IAA and ABA levels during culture 
synchronization 
No significant change could be observed in the cellular le- 
vels of IAA during culture synchronization, which ranged 
around 50 pmol/gfw (data not shown). ABA levels ranged 
around 40 pmol/gfw until 4 h after release from aphidicolin 
block and were below the detection limit thereafter (data not 
shown). The levels of IAA in the cell culture medium were 
close to or below the detection limit (0.5 pmol/ml), and simi- 
larly no ABA could be detected in the cell culture medium 
(detection limit of 0.5 pmol/ml) (data not shown). 
4. Discussion 
Correlation between cell cycle progression and endogenous 
levels of plant hormones was studied in synchronized tobacco 
BY-2 cell suspension cultures. No significant correlation could 
be identified for IAA and ABA, whose levels remained rather 
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Fig. 2. Analyses of cytokinin levels in synchronized BY-2 cells by 
LC-mass spectrometry (Exp. 2). (A) Mitotic index of the cells imme- 
diately before (0 h) and at different intervals after release from aphi- 
dicolin block. (B) Levels of Z (II), ZR G3) and ZMP (• )  in the 
synchronized cells (concentrations in pmol/average gfw of cells in a 
4-ml sample). (C) Levels of DZ (m), DZR ([]) and DZMP (• )  in 
the synchronized cells. 
low. Apparently BY-2 cells do not contain sufficient endoge- 
nous auxins to sustain their growth, as they are unable to 
divide in the absence of exogenous 2,4-D [29]. In contrast, 
we observed sharp peaks in the levels of specific cytokinins 
at specific phases of the cell cycle. Among the cytokinins 
analyzed, cell cycle-dependent fluctuations were identified 
only for the Z-type (Z, ZR, and ZMP) and for their dihydro 
derivates, but the magnitude of the peaks in the second group 
was lower. 
Sharp peaks in the levels of Z, ZR and DZR were corre- 
lated with the end of the S phase (around 3 h after release of 
the cells from aphidicolin block). In one of the three experi- 
ments presented here (Exp. 3), no significant change could be 
identified in the levels of Z and ZR at this stage. It is possible 
that putative peaks were missed due to the short duration of 
the increases in cytokinins levels in the course of synchronous 
growth. The occurrence of a small peak in DZR levels 3 h 
after release also in Exp. 3 supports this possibility. 
During mitosis, the levels of Z, ZR, and ZMP peaked in all 
three experiments, although to different levels. Thus, while Z 
peaked to comparable l vels in all three experiments, the peak 
of ZMP was higher than that of ZR in Exps. 1 and 2, while 
the opposite was seen in Exp. 3. This variation in the relative 
abundance of the nucleotide and riboside form of Z is coher- 
ent with the fact that these forms are interconvertable, but 
further study is required to know whether the physiological 
role of these compounds is similar, and which factors deter- 
mine their relative abundance. It is also interesting to note 
that in Exp. 1, in which the peak of mitotic index was broad 
compared to Exps. 2 and 3, the duration of the cytokinins 
peaks at this stage was also prolonged. The levels of the DZ- 
type cytokinins, that are formed by reduction of the zeatin 
side chains, were also increased at this stage of the cell cycle, 
to levels that were lower than, but proportional to, their cor- 
responding Z-type cytokinin. In Exp. 3, in which the peak in 
ZMP levels during mitosis was rather low, no increase in 
DZMP levels could be detected. 
Although in two of the three experiments an increase in Z 
levels was observed uring the G1 phase, following the de- 
crease of the mitotic index, further experiments need to con- 
firm this. 
Cytokinin O-glucosides are considered as a pool of biolo- 
gically inactive forms, that can be deglucosylated to release an 
active cytokinin and vice versa, while N-glucosides are extre- 
mely stable and may be important in regulating levels of ac- 
tive cytokinin through inactivation [30]. The cytokinin gluco- 
sides analyzed in this study (ZOG, DZOG, ZROG, DZROG, 
ZNG, and DZNG) were present at low and non-fluctuating 
levels throughout he entire cell cycle. Thus, the sharp in- 
creases in the levels of Z, DZ, ZR, and DZR at different 
stages of the cell cycle most probably results from their de 
novo synthesis and not from hydrolysis of their O-glucoside. 
Similarly, the sharp subsequent decrease in the levels of these 
cytokinins is not the result of inactivation by O-glucosylation, 
and at least for Z and DZ is also not a result of N-glucosyla- 
tion. At present he only plant enzyme known to catalyze the 
degradation of cytokinins to inactive products that lack the 
side-chain is cytokinin oxidase [31]. This enzyme cannot ac- 
cept cytokinin nucleotides as substrate and thus may only 
account for the rapid decrease in the levels of Z, DZ, ZR, 
and DZR. ZMP and DZMP need first to be dephosphory- 
lated to become a substrate for cytokinin-oxidase. 
An increase in cytokinin content at late S phase and during 
mitosis was also demonstrated by Nishinari and Syoni [32] 
using synchronized suspension cultures of the Nicotiana taba- 
cum L. cv. Xanthi cell strain XD6S. They measured concen- 
trations of only two cytokinins by thin layer chromatography, 
namely Z and ZR. As far as we are aware, the present study is 
the first in which 16 different naturally occurring cytokinins, 
as well as ABA and IAA, were simultaneously identified and 
quantified in synchronized plant cells by MS analysis with 
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Fig. 3. Analyses of cytokinin levels in synchronized BY-2 cells by 
LC-mass spectrometry (Exp. 3). For details, see legend to Fig. 2. 
detection limits of ,~ 1 pmol/gfw. The combination of immu- 
noaffinity purification and solid-phase xtraction allowed the 
identification of these hormones in very small quantities of 
cells (,,~ 0.25 gfw). 
Functional assays have suggested the involvement of cyto- 
kinins in the passage through several restriction points of the 
plant cell cycle. Cytokinins were found to be necessary for the 
entry of tobacco mesophyll protoplasts into S phase [10] and 
for the G2/M transition of tobacco and Glycine max suspen- 
sion cultures [9,11]. Crowell and Salaz [33] have shown that 
the growth of tobacco BY-2 cells is inhibited by low concen- 
trations of lovastatin, which inhibits the isoprenoid pathway 
that leads to the biosynthesis of the cytokinin side chain. This 
inhibition could be reversed by supplying Z to the medium, 
These data support our suggestion that fluctuations in the 
levels of specific cytokinins at distinct stages of the:cell cycle 
reflect their essential role during these phases. The question 
what is the nature of this role needs further study. As cyto- 
kinins are adenine analogues, one hypothesis to explain their 
action could be interfering with the activity of specific cell 
cycle-regulatory protein kinases at distinct points of the cell 
cycle. Such activity was recently shown for the cytokinin ana- 
logue olomoucine (2-(2-hydroxyethylamino)-6-benzylamino-9- 
methylpurine). It was shown that olomoucine, acting as a 
competitive inhibitor for ATP binding, specifically inhibits 
the activity of certain CDK-cyclin complexes and MAP ki- 
nases in vitro, while other protein kinases and CDK com- 
plexes, or even complexes of the same CDK with another 
cyclin, were not affected by low concentrations of this drug 
[34]. Analysis of CDK2/olomoucine crystals showed that the 
purine group of olomoucine is located in the pocket where 
ATP binds to CDK2 [35]. In vivo, olomoucine blocks plant 
cells at the G1/S and G2/M transitions [36]. Thus, according 
to this hypothesis, the general structure of the molecule (a 
specific cytokinin or a synthetic analogue such as olomoucine) 
may determine its specificity to certain CDK-cyclin com- 
plexes, or to other kinases, such as MAP kinases or the ki- 
nases that regulate CDK activity. All of these regulatory ki- 
nases need to be active only at restricted phases of the cell 
cycle and to be inactivated immediately thereafter. We are 
currently investigating whether specific cytokinins could actu- 
ally interfere with the activity of plant CDK-cyclin complexes. 
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